Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP)
IMPACt-LBP
Implementation of the American College of Physicians Guideline for Low Back Pain: A Cluster Randomized Trial (IMPACt-LBP)
1 other identifier
interventional
1,800
1 country
3
Brief Summary
The purpose of this study is to assess whether the primary spine practitioner (PSP) model of care will lead to improvements in patient outcomes, as compared to usual care, based on change in patient-reported PROMIS Pain Interference and Physical Function from baseline to 3 months in patients aged 18 years and older with a primary complaint of low back pain (LBP).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2022
CompletedFirst Posted
Study publicly available on registry
November 23, 2022
CompletedStudy Start
First participant enrolled
March 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
ExpectedApril 28, 2026
April 1, 2026
2.6 years
November 15, 2022
April 24, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Pain Interference as measured by PROMIS (Patient-Reported Outcomes Measurement Information System)
The Investigators will compare the change in PROMIS Pain Interference scores, individually, from baseline to 3- month follow-up between usual care and intervention arms.
Baseline, 3 Months
Change in Physical Function as measured by PROMIS (Patient-Reported Outcomes Measurement Information System)
The Investigators will compare the change in PROMIS Physical Function scores, individually, from baseline to 3- month follow-up between usual care and intervention arms.
Baseline, 3 Months
Secondary Outcomes (14)
NIH Low Back Pain Questions
Baseline, 12 Months
Patient Satisfaction
3 Months
Perceived Improvement
3 Months
Patient Experience
3 Months
Total Prescribed Opioid Dosage
Baseline, 3 Months, 6 Months, 12 Months
- +9 more secondary outcomes
Other Outcomes (10)
Total Prescribed Opioid Dosage
Up to approximately 24 Months
PROMIS Global 10 (v1.2) - Physical Health
Up to approximately 24 Months
PROMIS Global 10 (v1.2) - Mental Health
Up to approximately 24 Months
- +7 more other outcomes
Study Arms (2)
Usual Medical Care
ACTIVE COMPARATORThis group will consist of patients who contact clinics that have been randomized to usual medical care (no change to medical care).Usual care is defined as any care designated by a primary care physician (PCP).
Primary Spine Provider Model
EXPERIMENTALThis group will consist of patients who contact clinics that have been randomized to the primary spine provider (PSP) model (intervention clinics). Patients seeking care at intervention clinics will be given the option of seeing either a DC or a PT as their first contact clinician for an initial trial of PSP care.
Interventions
Patients with LBP seeking care at intervention clinics will be offered an appointment with a DC or PT at the initial point of contact.
Patients in this arm will receive usual care (no change to medical care).Usual care is defined as any care designated by a primary care physician (PCP).
Eligibility Criteria
You may qualify if:
- aged 18 years and older
- initiating an outpatient visit for LBP at a participating PCP clinic
- agree to participate and complete baseline questionnaire (in lieu of formal written documentation of consent)
You may not qualify if:
- inability to provide consent or complete outcome questionnaires
- positive screening for cauda equina symptoms (loss of total control of bowel/bladder associated with this episode of LBP )
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Duke Universitylead
- Dartmouth-Hitchcock Medical Centercollaborator
- University of Iowacollaborator
- Duke Healthcollaborator
- Palmer College of Chiropracticcollaborator
- National Center for Complementary and Integrative Health (NCCIH)collaborator
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)collaborator
Study Sites (3)
University of Iowa
Iowa City, Iowa, 52242, United States
Dartmouth Health
Lebanon, New Hampshire, 03755, United States
Duke Health
Durham, North Carolina, 27713, United States
Related Publications (1)
Goode AP, Goertz C, Chakraborty H, Salsbury SA, Broderick S, Levy BT, Ryan K, Settles S, Hort S, Dolor RJ, Chrischilles EA, Kasper S, Stahl JE, Almond C, Reed SD, Shannon Z, Harris D, Daly J, Winokur P, Lurie JD. Implementation of the American- College of Physicians Guideline for Low Back Pain (IMPACt-LBP): protocol for a healthcare systems embedded multisite pragmatic cluster-randomised trial. BMJ Open. 2025 Mar 26;15(3):e097133. doi: 10.1136/bmjopen-2024-097133.
PMID: 40139699BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christine Goertz, PhD
Duke Clinical Research Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Patients, clinicians delivering care, LBP schedulers and site research coordinators will not be blinded to clinic intervention assignment in this pragmatic clinical trial. There will be both blinded and unblinded analysis teams.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2022
First Posted
November 23, 2022
Study Start
March 14, 2023
Primary Completion
October 17, 2025
Study Completion (Estimated)
June 1, 2027
Last Updated
April 28, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- Data will not be shared until the end of the grant period (June 30, 2026).
- Access Criteria
- De-identified data or limited datasets for proposed use, with appropriate documentation, will be provided via secure transfer methods to the requestor following institutional approval and data use agreements as appropriate.
In collaboration with the NCCIH, the Investigators will develop a process to facilitate access to study data and will follow the Department of Health and Human Services guidance regarding HIPAA-compliant data sharing. Access to the limited dataset (Enrolled Cohort) will require a Data Use Agreement and IRB approval. This is a custom dataset created to include just the subset of data needed. Access to the de-identified dataset (Longitudinal Cohort) does not require a Data Use Agreement or IRB approval and is not subject to HIPAA's minimum necessary standards.